Back to top

Image: Bigstock

Merck (MRK) Jumps: Stock Rises 5.8%

Read MoreHide Full Article

Merck & Co., Inc. (MRK - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $56.11 to $58.66 in the past one month time frame.

The move came after the company announced positive results from a phase 3 study of its lung cancer drug.

The company has seen no estimate revisions over the past few weeks and the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Merck currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.  

A better-ranked stock in the Large Cap Pharmaceuticals industry is Bayer AG (BAYRY - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is MRK going up? Or down? Predict to see what others think: Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Merck & Co., Inc. (MRK) - free report >>

Bayer Aktiengesellschaft (BAYRY) - free report >>

Published in